Kidney Diseases  >>  verubecestat (MK-8931)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
verubecestat (MK-8931) / Merck (MSD)
NCT01537757: A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])

Completed
1
12
US
MK-8931
Merck Sharp & Dohme LLC
Alzheimer's Disease
05/12
05/12

Download Options